The relationship between cyclooxygenase-2 expression and colorectal cancer

JAMA

Volumn 282, Issue 13, 1999, Pages 1254-1257

  Shechan, Katherine M ^a,b   Shcahan, Kicran ^a   O'Donoghue, P ^b   Imacswecney, Fergus ^a,c   Conroy, Rouan M ^a,d   Fitzgerald, Desmond J ^e   Murray, Frank E ^a,b,c  

^a Departments of Clinical Pharmacology   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c Departments of Pathology

^d St Vincent Hospital   (United States)

^e BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; COLON BIOPSY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0033530260     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.13.1254     Document Type: Article

References (34)

1. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the US. Cancer. 1999;85: 1670-1676.
2. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 1932:35:323-332.
3. Chapuis P, Dent O, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. BrJSurg. 1985:72:698-702.
4. Thun MJ, Namboodiri MM, Health CW Jr. Aspirin use and reduced risk of fatal colon cancer. W Engl J Med 1991;325:1593-1596.
5. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications. Cancer Res. 1988:48:4399-4404.
6. Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R, for the polyp prevention group. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst. 1993:85:912-916.
7. Marnett U. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 1992:52:5575-5589.
8. Sandier RS, Galanko JC, Murray SC, Helm JF, Woosley JT. Aspirin and non-steroidal anti-inflammatory agents and risk for colorectal adenomas. Castroenterology. 1998;114:441-447.
9. Giardello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenoma with sulindac in familial adenomatous polyposis. N Engl J Med. 1993; 328:1313-1316.
10. HlaT, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sei USA. 1992:89:7384-7388.
11. Jones DA, Carlton DP, Mclntyre TM, et al. Molecular cloning of human endoperoxide synthase type 11 and demonstration of expression in response to cytokines. I Biol Chem. 1993:268:9049-9054.
12. DuBois RN, Tsujii M, Bishop P, et al. Cloning and characterization of growth factor inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol. 1994;266:G822-G827.
13. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colon cancer. Cancer Res. 1995;55:3785-3789.
14. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Ape A716 knockout mice by inhibition of cydooxygenase-2 (COX2). Cell. 1996;87:803-809.
15. Skelly MM, Troy A, Duffy MJ, et al. Urokinasetype plasminogen activator in colorectal cancer. Clin Cancer Res. 1997:3:1837-1840.
16. Mulcahy HE, Duffy Ml, Gibbons D, et al. Urokinasetype plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet. 1994;344:583-584.
17. Jass JR, Morson BC. Reporting colorectal cancer. J Clin Pat/70J. 1987;40:1016-1023.
18. Shepherd NA, Saraga E-P, Love SB, Jass JR. Prognostic factors in colon cancer. Histopathology. 1989: 14:613-620.
19. Graham DM, Appelman HD. Crohns-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. ModPathol. 1990:3:332-335.
20. Mulcahy HE, Toner M, Patchett SE, Daly L, O'Donoghue DP. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum. 1997;40:3, 326-330.
21. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. ProcNatlAcadSciUSA. 1997:94:3336-3340.
22. Fujita T, Matsui M, Takaku K, et al. Size- and invasion-dependent increase in cyclooxygenase-2 levels in human colorectal carcinomas. Cancer Res. 1998; 58:4823-4826.
23. Yang VW, Sheilds JM, Hamilton SR, et al. Sizedependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res. 1998:58:1750-1753.
24. Kargman SL, O'Neill GP, Vickers PJ, et al. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res. 1995:55:2556-2559.
25. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest. 1997;100:1325-1329.
26. Metzger U, Meier J, Uhlschmid G, Weihe H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum. 1984:27:366-369.
27. Jacoby RF, Marshall DJ, Newton MA, et al. Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the non-steroidal antiinflammatory drug piroxicam. Cancer Res. 1996;56: 710-714.
28. Moorghen M, Ince P, Finney KJ, SunterJP, Appleton DR, Watson AJ. A protective effect of sulindac against chemically induced primary colonic tumors in mice. J Pathol. 1988;156:341-347.
29. Barnes CI, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroentero/ogy. 1998:114:873-877.
30. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med. 1993:122:518-523.
31. Elder DJ, Haiton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carinoma cell lines by a cyclooxygenase-2 selective NSAID. Clin Cancer Res. 1997;3:1679-1683.
32. Shiff SJ, Qiao L, Tsai L, Rigas B. Sulindac sulfide, an aspirin-like-compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 adenocarcinoma cells. J Clin Invest. 1995;96:491 -503.
33. Pasricha PJ, Bedi A, O'Connor K, et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology. 1995:109:994-998.
34. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuSbis RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998:93:705-716.